Skip to main content
. 2020 Mar 11;2020:2513578. doi: 10.1155/2020/2513578

Table 3.

ART treatment and other medication-related characteristics of patients.

Characteristics Frequency Percentage

ART eligibility criteria CD4 < 350 and WHO stage IV 16 6.8
WHO stage II and III 26 10.9
Without criteria 195 82.3
OI prophylaxis Yes 225 94.9
No 12 —
ART side effects during follow-up Yes 130 54.8
No 107 45.2
Regimen change during follow-up Yes 103 43.3
No 134 56.7